Trial intelligence / Profile preview

Effect of sufentanil on the depth of anesthesia in patients with irreversible pulpitis

IRCT201110137790N1Phase 2Completed

Sponsor
Islamic Azad University
Start
Oct 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of sufentanil in irreversible pulpitis, sponsored by Islamic Azad University. Primary endpoint: Depth or adequacy of anesthesia. Started Oct 2010; status: completed.

02

Drugs

sufentanil
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on IRCT201110137790N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201110137790N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call